AUROLAB

Auro Laboratories Ltd, incorporated in 1989, is an India-based pharmaceutical company operating within the pharmaceutical and healthcare industries. The company specializes in the manufacturing of Active Pharmaceutical Ingredients (APIs) and intermediates, focusing particularly on bulk drugs. Its product portfolio includes anti-diabetic agents, muscle relaxant agents, antihistamine agents, and notably Metformin Hydrochloride, a key medication for type 2 diabetes management. Auro Laboratories Ltd serves both domestic Indian and international markets. The company does not have any listed subsidiaries or ventures and is not listed on any stock exchange. No information about founders or key management is provided.